| |
Latest 10 SEC filings (by transaction date) for RNA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 22/24 | Apr 19/24 | Levin Arthur A | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Apr 22/24 | Apr 19/24 | Levin Arthur A | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $22.82 |
Apr 22/24 | Apr 19/24 | Levin Arthur A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $1.24 |
Apr 3/24 | Apr 3/24 | Levin Arthur A | Indirect Ownership | Common Stock | S - Open market or private sale | -20,000 | $27.11 |
Apr 3/24 | Apr 2/24 | Boyce Sarah | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -28,000 | |
Apr 3/24 | Apr 2/24 | Boyce Sarah | Direct Ownership | Common Stock | S - Open market or private sale | -28,000 | $26.25 |
Apr 3/24 | Apr 2/24 | Boyce Sarah | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,000 | $1.24 |
Mar 21/24 | Mar 19/24 | Levin Arthur A | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 21/24 | Mar 19/24 | Levin Arthur A | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $23.97 |
Mar 21/24 | Mar 19/24 | Levin Arthur A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $1.24 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RNA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 22/24 | Apr 19/24 | Levin Arthur A | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Apr 22/24 | Apr 19/24 | Levin Arthur A | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $22.82 |
Apr 22/24 | Apr 19/24 | Levin Arthur A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $1.24 |
Apr 3/24 | Apr 3/24 | Levin Arthur A | Indirect Ownership | Common Stock | S - Open market or private sale | -20,000 | $27.11 |
Apr 3/24 | Apr 2/24 | Boyce Sarah | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -28,000 | |
Apr 3/24 | Apr 2/24 | Boyce Sarah | Direct Ownership | Common Stock | S - Open market or private sale | -28,000 | $26.25 |
Apr 3/24 | Apr 2/24 | Boyce Sarah | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,000 | $1.24 |
Mar 21/24 | Mar 19/24 | Levin Arthur A | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 21/24 | Mar 19/24 | Levin Arthur A | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $23.97 |
Mar 21/24 | Mar 19/24 | Levin Arthur A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $1.24 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |